Documents D. Gillen, FDA Repro, Jan 23-241 Statistical Issues in Contraceptive Trials Daniel L. Gillen, PhD...

Slide 1 D. Gillen, FDA Repro, Jan 23-241 Statistical Issues in Contraceptive Trials Daniel L. Gillen, PhD Department of Statistics University of California, Irvine FDA Reproductive…

Documents 1 Setting the Record Straight ALLHAT. 2 Major ALLHAT Findings CHD risk not improved for any of the 3...

Slide 1 1 Setting the Record Straight ALLHAT Slide 2 2 Major ALLHAT Findings CHD risk not improved for any of the 3 newer agents compared with chlorthalidone Total mortality…

Documents Setting the Record Straight

Setting the Record Straight Major ALLHAT Findings CHD risk not improved for any of the 3 newer agents compared with chlorthalidone Total mortality was similar for the 4 groups…